Loading the content... Loading depends on your connection speed!

Shopping Cart - $0.00

Colorectal Cancer Market Global Briefing 2017

Colorectal Cancer Market Global Briefing 2017

From $1,000.00

Including: Drugs For – Adenocarcinomas, Metastatic Colorectal Cancer, Gastrointestinal Carcinoid Tumors, And Other Colorectal Cancer.
Covering: F. Hoffmann-La Roche, Merck & Co, Celgene


Clear selection
SKU: 2259. Category: .
Description

Colorectal Cancer Market Global Briefing 2017 from The Business Research Company provides the strategists, marketers and senior management with the critical information they need to assess the global colorectal cancer market.

Description

The Colorectal Cancer Market Global Briefing Report from The Business Research Company covers market characteristics, size and growth, segmentation, regional breakdowns, competitive landscape, market shares, trends and strategies for this market.

The colorectal cancer market is one of the segments in the oncology drugs market, within the pharmaceutical drugs market.

The market characteristics section of the report defines and explains the market.

The market size section gives the colorectal cancer market revenues, covering both the historic growth of the market and forecasting the future.

Drivers and restraints looks at the external factors supporting and controlling the growth of the market.

Market segmentations break down the key sub sectors which make up the market. The regional breakdowns section gives the size of the market geographically.

Competitive landscape gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in the last three years are identified.

The trends and strategies section highlights the likely future developments in the colorectal cancer market and suggests approaches.

Reasons to Purchase

• Get up to date information available on the colorectal cancer market globally.
• Identify growth segments and opportunities.
• Facilitate decision making on the basis of historic and forecast data and understand the drivers and restraints on the market.
• Develop strategies based on likely future developments.
• Gain a global perspective on the development of the market.
• Report will be updated with the latest data and delivered to you within 2-3 working days of order.

Scope

Markets Covered: Drugs For – Adenocarcinomas, Metastatic Colorectal Cancer, Gastrointestinal Carcinoid Tumors, and Other Colorectal Cancer.

Companies Mentioned: F. Hoffmann-La Roche, Merck & Co, Celgene.

Countries: Brazil, China, France, Germany, India, Italy, Japan, Spain, Russia, UK, USA and Australia.

Regions: Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East And Africa

Time series: Five years historic and forecast.

Data: Market value in $ billions.

Data segmentations: Regional breakdowns, market share of competitors, key sub segments.

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

Related Reports:
Lung cancer Market Global Briefing 2017
Pancreatic cancer Market Global Briefing 2017
Breast cancer Market Global Briefing 2017
Prostate cancer Market Global Briefing 2017
Ovarian cancer Market Global Briefing 2017
Gastric Cancer Market Global Briefing 2017
Non-Small Cell Lung Cancer Market Global Briefing 2017
Brain Tumor Market Global Briefing 2017
Thyroid cancer Market Global Briefing 2017
Bladder Cancer Market Global Briefing 2017
Kidney Cancer Market Global Briefing 2017
Skin cancer Market Global Briefing 2017
Cervical Cancer Market Global Briefing 2017
Blood cancer Market Global Briefing 2017

Table Of Contents
Table Of Contents

1. Introduction
2. Colorectal Cancer Market Characteristics
3. Colorectal Cancer Market Historic Growth
• Drivers Of The Market
• Restraints On The Market
4. Colorectal Cancer Market Forecast Growth
• Drivers Of The Market
• Restraints On The Market
5. Colorectal Cancer Market Geography Split
6. Colorectal Cancer Market As A Proportion of Oncology Drugs Market, 2016, By Region
7. Colorectal Cancer Market As A Proportion of Oncology Drugs Market, 2016, By Country
8. Colorectal Cancer Market Segmentation
9. Colorectal Cancer Competitive Landscape
F. Hoffmann-La Roche
Merck & Co
Celgene
10. Key Mergers And Acquisitions In The Colorectal Cancer Market
11. Colorectal Cancer Market Trends And Strategies
Appendix
NAICS Definitions of Industry Covered In This Report
Research Methodology
Methodology
Data
Market Numbers
Competitor Market Share Data
Analysis
Verification Through Expert Interviews
Referencing
Note on Currency Conversions
Abbreviations
Currencies
Research Inquiries
The Business Research Company

List Of Tables
Table 1: Global Colorectal Cancer Market Historic Market Size, 2012 – 2016, $ Billion
Table 2: Global Colorectal Cancer Market Forecast Market Size, 2016 – 2020, $ Billion
Table 3: Global Colorectal Cancer Market, Split By Region, 2016, $ Billion
Table 4: Colorectal Cancer Market As A Proportion of Oncology Drugs Market, 2016, By Region
Table 5: Colorectal Cancer Market As A Proportion of Oncology Drugs Market, 2016, By Country
Table 6: Global Colorectal Cancer Market, Key Competitor Shares, 2016, Percentage (%)
Table 7: Global Colorectal Cancer Market, Split By Segments, 2016, $ Billion

List Of Figures
Figure 1: Global Colorectal Cancer Market Historic Market Size, 2012 – 2016, $ Billion
Figure 2: Global Colorectal Cancer Market Forecast Market Size, 2016 – 2020, $ Billion
Figure 3: Global Colorectal Cancer Market, Split By Region, 2016, $ Billion
Figure 4: Colorectal Cancer Market As A Proportion of Oncology Drugs Market, 2016, By Region
Figure 5: Colorectal Cancer Market As A Proportion of Oncology Drugs Market, 2020, By Country
Figure 6: Global Colorectal Cancer Market, Key Competitor Shares, 2016, Percentage (%)
Figure 7: Global Colorectal Cancer Market, Split By Segments, 2016, $ Billion
Executive Summary
The colorectal cancer drugs market cover drugs that treat cancer that affect colon and rectum. These conditions include adenocarcinomas, metastatic colorectal cancer, gastrointestinal carcinoid tumors, and other colorectal cancer. Some of the major drugs in this market are Ziv-Aflibercept, Zaltrap (Ziv-Aflibercept), Xeloda (Capecitabine), Wellcovorin (Leucovorin Calcium), Vectibix (Panitumumab), Trifluridine and Tipiracil Hydrochloride, Stivarga (Regorafenib), Regorafenib, Ramucirumab, Panitumumab, Oxaliplatin, Lonsurf (Trifluridine and Tipiracil Hydrochloride), Leucovorin Calcium, Irinotecan Hydrochloride, Fluorouracil Injection, Erbitux (Cetuximab), Eloxatin (Oxaliplatin), Cyramza (Ramucirumab), Cetuximab, Capecitabine, Camptosar (Irinotecan Hydrochloride), Bevacizumab, Avastin (Bevacizumab), and 5-FU (Fluorouracil Injection). Based on the mode of administration, the market is segmented into oral and parenteral segments. Based on type of molecule, the market is segmented into biologics and small molecules.

The global colorectal cancer market was estimated to be around $8.7 billion as of 2016. The global colorectal cancer made up around 7% of the overall oncology drugs market in 2016. The colorectal cancer market was the fifth largest market in the global oncology drugs market in 2016.

Combination Therapies For Colorectal Cancer
R&D of combination drug therapies for the treatment of ovaraina cancer is one of the major trend in this market. Some of the drug combinations used for the treatment of colon cancer are XELOX, XELIRI, FU-LV, FOLFOX, FOLFIRI-CETUXIMAB, FOLFIRI-BEVACIZUMAB, FOLFIRI, and CAPOX. For instance, in June 2017, Novartis and Bristol-Myers Squibb entered into clinical research collaboration in which Bristol-Myers Squibb will investigate efficacy and safety of Mekinist (trametinib) drug when used in combination with Opdivo (nivolumab) for the treatment metastatic colorectal cancer.
Get Customized Report
Please fill in your details. Our team will get back to you